Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

Share Price is delayed by 15 minutes
Get Live Data
139.50    0.00 (0.00%)
Bid:
137.00
Ask:
142.00
Spread: 5.00 (3.65%)
Market Cap: £78.87m
MVI Live PriceLast checked at - London Stock Exchange

Intraday Marwyn Val. Share Chart

Share Transfer

26 Mar 2026 13:30

RNS Number : 2821Y
Marwyn Value Investors Limited
26 March 2026
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

 

LEI: 213800L5751QTTVEA774

26 March 2026

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

SHARE TRANSFER

The Company today announces that it was notified that Antoinette Vanderpuije, partner of Marwyn Investment Management LLP, the manager of the Company, sold 21,180 Ordinary Shares at a price of 134.0 pence per share from her General Investment Account and purchased 21,180 Ordinary Shares for her SIPP and personal ISA accounts at a price of 134.15 pence per share.

Following this transfer, Antoinette Vanderpuije's holding of Ordinary Shares remains unchanged at 231,259 Ordinary Shares, representing approximately 0.41% of the Company's total voting rights.

Whilst Antoinette Vanderpuije is not a Person Discharging Managerial Responsibility ("PDMR") within the meaning of the UK version of Regulation (EU) 596/2014, as incorporated in the UK by virtue of the European Union (Withdrawal) Act 2018, as amended in relation to the Company, she has voluntarily disclosed the information above to the Company, and the Company is voluntarily disclosing the information above to the market, as if she was a PDMR in relation to the Company.

Company enquiries:

Marwyn Value Investors Limited

Scott Danks

scottdanks@marwyn.com

 

Company Secretary - Palmer Fund Services (Jersey) Limited

marwyn@palmerfs.com

1 Grenville Street

St Helier

Jersey JE2 4UF

 

Investor Relations - KK Advisory Limited

Kam Bansil

020 7039 1901

 

PR Adviser - FGS GlobalRollo Head 07768 994987Chris Sibbald 07855 955531

 

Corporate Broker - Panmure Liberum Limited

Chris Clarke

0203 100 2200

 

Note:

Shares in the Company are not designed or intended for retail investors. Marwyn Investment Management LLP, the Manager, does not promote shares in the Company to retail investors and they should not be offered to retail investors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFFVVIRFIR
Date   Source Headline
12th May 202511:00 amRNSNet Asset Values
2nd May 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd May 202510:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd May 202510:00 amRNSNet Asset Value - Ordinary Shares
30th Apr 20257:00 amRNSInterim Dividend to Ordinary Shareholders
28th Apr 20257:00 amRNSAnnual Financial Report
22nd Apr 202511:00 amRNSNet Asset Values
15th Apr 202511:00 amRNSNet Asset Values
14th Apr 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
14th Apr 202510:05 amRNSNet Asset Value - 2016 Realisation Shares
14th Apr 202510:00 amRNSNet Asset Value - Ordinary Shares
27th Mar 20252:00 pmRNSShare Dealings
27th Mar 20258:00 amRNSInvestAcc Acquisition
24th Mar 202511:00 amRNSNet Asset Values
17th Mar 202511:00 amRNSNet Asset Values
10th Mar 202511:00 amRNSNet Asset Values
4th Mar 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
4th Mar 202510:05 amRNSNet Asset Value - 2016 Realisation Shares
4th Mar 202510:00 amRNSNet Asset Value - Ordinary Shares
24th Feb 202511:00 amRNSNet Asset Values
17th Feb 202511:00 amRNSNet Asset Values
10th Feb 202511:00 amRNSNet Asset Values
4th Feb 202510:10 amRNSNet Asset Value - 2021 Realisation Shares
4th Feb 202510:05 amRNSNet Asset Value - 2016 Realisation Shares
4th Feb 202510:00 amRNSNet Asset Value - Ordinary Shares
30th Jan 20257:00 amRNSInterim Dividend to Ordinary Shareholders
27th Jan 202511:00 amRNSNet Asset Values
20th Jan 202511:00 amRNSNet Asset Values
16th Jan 202511:00 amRNSNet Asset Values
15th Jan 20258:10 amRNSNet Asset Value - 2021 Realisation Shares
15th Jan 20258:05 amRNSNet Asset Value - 2016 Realisation Shares
15th Jan 20258:00 amRNSNet Asset Value - Ordinary Shares
2nd Jan 20259:01 amRNSChange of Administrator and Correspondence Address
23rd Dec 202411:00 amRNSNet Asset Values
16th Dec 202411:00 amRNSNet Asset Values
9th Dec 20244:21 pmRNSShare Dealings
9th Dec 202412:00 pmRNSResult of AGM
9th Dec 202411:00 amRNSNet Asset Values
3rd Dec 202410:10 amRNSNet Asset Value – 2021 Realisation Shares
3rd Dec 202410:05 amRNSNet Asset Value – 2016 Realisation Shares
3rd Dec 202410:00 amRNSNet Asset Value – Ordinary Shares
25th Nov 202411:00 amRNSNet Asset Values
18th Nov 202411:00 amRNSNet Asset Values
11th Nov 202411:00 amRNSNet Asset Values
4th Nov 202410:10 amRNSNet Asset Value – 2021 Realisation Shares
4th Nov 202410:05 amRNSNet Asset Value – 2016 Realisation Shares
4th Nov 202410:00 amRNSNet Asset Value – Ordinary Shares
1st Nov 20247:00 amRNSNotice of Annual General Meeting
31st Oct 20247:00 amRNSInterim Dividend to Ordinary Shareholders
21st Oct 202411:00 amRNSNet Asset Values

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.